logo-loader

Insight Widest with the analysis. We look at the companies others don’t, giving access to the opportunities others won’t.

Acasti Pharma eyeing FDA meeting as it continues to advance heart...

A pre-clinical mouse study last year of the drug also offered new insights into a potential mechanism of...

Opinion We bridge the gap between knowledge and ignorance and give you the angle that hard facts alone won’t

Research Independent research from the expert Proactive analyst team

biotech

Strategic Minerals

MaxCyte: Allogene deal is validation for new CAR-T wave

Health

Shield Therapeutics...

Shield Therapeutics (STX) detailed a series of achievements in its FY19 business...